[No over-coagulation occurs if the therapeutic guidelines of a thromboplastin inhibitor are followed].
D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006470:Hemorrhage / Q000517:prevention & control; D006801:Humans; D010314:Partial Thromboplastin Time; D013925:Thromboplastin / Q000037:antagonists & inhibitors*; D013927:Thrombosis / Q000517:prevention & control*
D000925:Anticoagulants; D013925:Thromboplastin
Keine Uberantikoagulation bei Befolgung der therapeutischen Empfehlungen eines Thromboplastin-Vertreibers.